By Global Health Security Team
New data show the risk of a serious blood clot from AstraZeneca jab has doubled in a fortnight – but the Government’s regulatory agency has said the benefits still outweigh the risks.
Cases have gone up from 79 to 168 and deaths from 19 to 32, according to the Government’s Yellowcard system which allows people to report vaccine side-effects.
The chance of having a clot has gone from one in 250,000 to one in 126,582.
Rare blood clot events occurred in 93 women and 75 men, aged between 18 and 93, with a case fatality rate of 19 per cent, with 32 deaths.
“On the basis of this ongoing review, the advice remains that the benefits of the vaccine outweigh the risks in the majority of people,” the MHRA has said.
It comes as new figures showed that coronavirus was no longer the leading cause of death in both England and Wales last month for the first time since October.
Elsewhere, universities in the have offered to “hotel quarantine” students from “red listed” India amid concerns the Government will not be able to cope with an influx of up to 50,000 from the country.
Below is a summary of today’s coronavirus-related developments: